Market Cap 48.79M
Revenue (ttm) 0.00
Net Income (ttm) -90.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 323,900
Avg Vol 360,620
Day's Range N/A - N/A
Shares Out 48.31M
Stochastic %K 97%
Beta -0.73
Analysts Strong Sell
Price Target $6.50

Company Profile

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its na...

Industry: Biotechnology
Sector: Healthcare
Phone: 512 501 2444
Address:
6801 N. Capital of Texas Highway, Building 1, Austin, United States
chelseacole
chelseacole Aug. 4 at 9:01 AM
$FLNA load up on this
1 · Reply
Shawshank_book_keeper
Shawshank_book_keeper Aug. 4 at 7:23 AM
$FLNA how is this trading on Nasdaq? It’s a fraud of a company with no real science! Wall Street is criminal.
1 · Reply
BioGLovesMe
BioGLovesMe Aug. 3 at 6:11 PM
$FLNA You guys into poopoo?
0 · Reply
Chrissytina
Chrissytina Jul. 31 at 5:35 PM
$FLNA This must close over $1.00 for 10 days or it’s all over!!!
1 · Reply
PeterRaslow
PeterRaslow Jul. 30 at 9:26 PM
$FLNA is chance for alchemies here ?
0 · Reply
JunkPost
JunkPost Jul. 30 at 8:02 PM
$FLNA Nice close. We will see tomorrow
0 · Reply
GangsterX
GangsterX Jul. 30 at 6:46 PM
$FLNA Loaded .93... News in August. If down, add more
1 · Reply
JumpStarting
JumpStarting Jul. 30 at 5:16 PM
$FLNA That 'NA' field is just a retail algorithm lag behind the rebrand. Look right past it to the Top 38% Zacks Sector Rank in your image, backed by a unanimous 1.00 analyst Strong Buy. The real data completely de-risks this: • Lawsuit Dead: The $31.25M settlement is fully paid into escrow. Legal cloud gone. • Massive Cash: Guided to finish 2026 with up to $40M in unrestricted, debt-free cash after a lean H2 operational burn. • FDA Hold: It's a standard pre-clinical protocol tweak for their TSC-epilepsy drug, with data submissions underway.
0 · Reply
BioGLovesMe
BioGLovesMe Jul. 30 at 4:00 PM
$FLNA Notice how the permabaggies emerge from their desperate sorrow on a dead cat bounce, pretending like they know what's going on. Don't let them fool you. Stay far away from this junk bio or become a member of their twisted club.
0 · Reply
Bricktop200
Bricktop200 Jul. 30 at 2:33 PM
$FLNA I will come back end of year when this $7 a pop.
1 · Reply
Latest News on FLNA
Filana Therapeutics Earnings release: Q2 2026

Jul 29, 2026, 8:30 AM EDT - 6 days ago

Filana Therapeutics Earnings release: Q2 2026


Filana Therapeutics Quarterly report: Q2 2026

Jul 29, 2026, 8:30 AM EDT - 6 days ago

Filana Therapeutics Quarterly report: Q2 2026


Filana Therapeutics Slides: Corporate presentation

Jul 29, 2026, 7:00 AM EDT - 6 days ago

Filana Therapeutics Slides: Corporate presentation


Filana Therapeutics Transcript: AGM 2026

Jun 11, 2026, 9:30 AM EDT - 7 weeks ago

Filana Therapeutics Transcript: AGM 2026


Filana Therapeutics resumed with a Buy at Maxim

2026-05-26T12:40:15.000Z - 2 months ago

Filana Therapeutics resumed with a Buy at Maxim


Filana Therapeutics Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Filana Therapeutics Earnings release: Q1 2026


Filana Therapeutics Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Filana Therapeutics Quarterly report: Q1 2026


Filana Therapeutics Slides: Corporate presentation

May 7, 2026, 7:00 AM EDT - 3 months ago

Filana Therapeutics Slides: Corporate presentation


Filana Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Filana Therapeutics Proxy statement: Proxy filing


Filana Therapeutics publishes simufilam preclinical data

2026-04-15T12:20:15.000Z - 3 months ago

Filana Therapeutics publishes simufilam preclinical data


Filana Therapeutics management to meet with Maxim

2026-03-19T19:25:18.000Z - 4 months ago

Filana Therapeutics management to meet with Maxim


Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year

2026-03-12T12:13:27.000Z - 5 months ago

Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year


Filana Therapeutics Annual report: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 5 months ago

Filana Therapeutics Annual report: Q4 2025


Filana Therapeutics Earnings release: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 5 months ago

Filana Therapeutics Earnings release: Q4 2025


Filana Therapeutics Slides: Investor presentation

Mar 10, 2026, 7:00 AM EDT - 5 months ago

Filana Therapeutics Slides: Investor presentation


Filana Therapeutics Registration statement: Registration Filing

Nov 13, 2025, 7:00 AM EST - 9 months ago

Filana Therapeutics Registration statement: Registration Filing


Filana Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 9 months ago

Filana Therapeutics Quarterly report: Q3 2025


Filana Therapeutics Earnings release: Q3 2025

Nov 12, 2025, 8:00 AM EST - 9 months ago

Filana Therapeutics Earnings release: Q3 2025


Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

Oct 22, 2025, 8:00 AM EDT - 10 months ago

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors


Filana Therapeutics Quarterly report: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Quarterly report: Q2 2025


Filana Therapeutics Earnings release: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Earnings release: Q2 2025


Filana Therapeutics Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Filana Therapeutics Quarterly report: Q1 2025


Filana Therapeutics Earnings release: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Filana Therapeutics Earnings release: Q1 2025


Filana Therapeutics Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Proxy statement: Proxy Filing


Filana Therapeutics Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Proxy statement: Proxy Filing


Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Mar 25, 2025, 8:05 AM EDT - 1 year ago

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data


Filana Therapeutics Annual report: Q4 2024

Mar 3, 2025, 7:30 AM EST - 1 year ago

Filana Therapeutics Annual report: Q4 2024


Filana Therapeutics Earnings release: Q4 2024

Mar 3, 2025, 7:30 AM EST - 1 year ago

Filana Therapeutics Earnings release: Q4 2024


Cassava Sciences Provides a Business Update

Jan 7, 2025, 4:30 PM EST - 1 year ago

Cassava Sciences Provides a Business Update


chelseacole
chelseacole Aug. 4 at 9:01 AM
$FLNA load up on this
1 · Reply
Shawshank_book_keeper
Shawshank_book_keeper Aug. 4 at 7:23 AM
$FLNA how is this trading on Nasdaq? It’s a fraud of a company with no real science! Wall Street is criminal.
1 · Reply
BioGLovesMe
BioGLovesMe Aug. 3 at 6:11 PM
$FLNA You guys into poopoo?
0 · Reply
Chrissytina
Chrissytina Jul. 31 at 5:35 PM
$FLNA This must close over $1.00 for 10 days or it’s all over!!!
1 · Reply
PeterRaslow
PeterRaslow Jul. 30 at 9:26 PM
$FLNA is chance for alchemies here ?
0 · Reply
JunkPost
JunkPost Jul. 30 at 8:02 PM
$FLNA Nice close. We will see tomorrow
0 · Reply
GangsterX
GangsterX Jul. 30 at 6:46 PM
$FLNA Loaded .93... News in August. If down, add more
1 · Reply
JumpStarting
JumpStarting Jul. 30 at 5:16 PM
$FLNA That 'NA' field is just a retail algorithm lag behind the rebrand. Look right past it to the Top 38% Zacks Sector Rank in your image, backed by a unanimous 1.00 analyst Strong Buy. The real data completely de-risks this: • Lawsuit Dead: The $31.25M settlement is fully paid into escrow. Legal cloud gone. • Massive Cash: Guided to finish 2026 with up to $40M in unrestricted, debt-free cash after a lean H2 operational burn. • FDA Hold: It's a standard pre-clinical protocol tweak for their TSC-epilepsy drug, with data submissions underway.
0 · Reply
BioGLovesMe
BioGLovesMe Jul. 30 at 4:00 PM
$FLNA Notice how the permabaggies emerge from their desperate sorrow on a dead cat bounce, pretending like they know what's going on. Don't let them fool you. Stay far away from this junk bio or become a member of their twisted club.
0 · Reply
Bricktop200
Bricktop200 Jul. 30 at 2:33 PM
$FLNA I will come back end of year when this $7 a pop.
1 · Reply
Bricktop200
Bricktop200 Jul. 30 at 2:33 PM
$FLNA bought more.
1 · Reply
Chrissytina
Chrissytina Jul. 30 at 2:24 PM
$FLNA Almost 5 cents, get ready for the drop 🤣 penny flippers still here!
0 · Reply
To_De_Moon
To_De_Moon Jul. 30 at 2:22 PM
$FLNA $MSFT rip it
2 · Reply
9Volt
9Volt Jul. 30 at 6:03 AM
$FLNA Game Over, lost all my Money ....
0 · Reply
ZacksResearch
ZacksResearch Jul. 29 at 6:50 PM
$FLNA slashed its quarterly loss — but the FDA overhang is still the key story. 📊 Q2 net loss improved to $8.6M ($0.18/share) from $44.2M ($0.92/share) a year ago. 💵 Ended the quarter with $82.7M in cash and no debt, while first-half operating cash burn came in below previous guidance. 📉 R&D expenses fell 35% YoY and G&A expenses dropped 85% YoY, reflecting the completed Alzheimer's program and the absence of last year's litigation charge. ⚠️ Meanwhile, Filana continues working with the FDA to lift the clinical hold on its TSC-related epilepsy trial. See what Wall Street expects next 👉 https://www.zacks.com/stock/research/FLNA/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-39023&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_39023
0 · Reply
focafoca99
focafoca99 Jul. 29 at 5:44 PM
$FLNA outlined Q2 2026 results with $82.7M cash, no debt, and a $31.25M escrow for a securities litigation settlement. https://www.rapidticker.com/news/flna-filana-therapeutics-reports-q2-2026-cae711
0 · Reply
Scudriel
Scudriel Jul. 29 at 3:58 PM
$FLNA good results
2 · Reply
donrubin
donrubin Jul. 28 at 8:16 PM
$FLNA 3.11 was PO price as far as I remember. I guess after reverse split at 0.31 :)
0 · Reply
JumpStarting
JumpStarting Jul. 27 at 5:22 PM
$FLNA is a strong buy? (Zack)
2 · Reply
ZacksResearch
ZacksResearch Jul. 27 at 4:09 PM
$FLNA is up 2% in trading. Is this a reversal sign? Can the stock rebound from the lows? See what Wall Street expects next 👉 https://www.zacks.com/stock/research/FLNA/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38986&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38986
1 · Reply
donrubin
donrubin Jul. 27 at 1:33 PM
$FLNA it seems there is a leak they shit all over with experiments.
2 · Reply
jackcoltrain
jackcoltrain Jul. 27 at 1:49 AM
$SLS when morons fall in love with a biotech stock, it's time to short! We've seen the same behavior in shitcos like $CVM and $FLNA (formerly $SAVA) - retail traders thought they were experts in cancer and alzheimer's treatment, and lost a lot of money!